Delivery Order SPE2DB24D2216-SPE2DB25FGMPE

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Avonex prefilled syringes. The Delivery Order contract, valued at $11,084.60, has a firm fixed-price pricing type and an ultimate completion date of June 25, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of AVONEX PEN 30 MCG/0.5 ML KITS to the Defense Logistics Agency (DLA). The $49,724.48 firm fixed-price delivery order has a period of performance through November 14, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract is a delivery order valued at $16,541.86 for the supply of AVONEX PREFILLED SYR 30 MCG KTS, a multiple sclerosis medication. The contract has a firm-fixed price pricing type and an ultimate completion date of September 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,942.38 firm fixed-price delivery order is for the supply of AVONEX PEN 30 MCG/0.5 ML KITS, a specialty medication. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of AVONEX PEN 30 MCG/0.5 ML KITS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,983.92 and an ultimate completion date of November 1, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $45,259.30 Firm Fixed Price delivery order is for the procurement of 4565630942 AVONEX PREFILLED SYR 30 MCG KTS, a pharmaceutical product. This award is not associated with a set-aside. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $11,975.85 delivery order is for the supply of AVONEX PEN 30 MCG/0.5 ML KITS, a specialty pharmaceutical product. The contract has a firm fixed price and no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AVONEX PEN 30 MCG/0.5 ML KITS to the Defense Logistics Agency (DLA), a major defense agency. The single-award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,991.96 firm-fixed-price delivery order is for the supply of AVONEX PREFILLED SYR 30 MCG KTS, a specialty pharmaceutical product, to support military treatment programs. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AVONEX PREFILLED SYR 30 MCG KTS medical supplies. The $54,885.89 firm fixed-price delivery order contract has an ultimate completion date of December 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGMPE
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $8,479.72 for the supply of Avonex Prefilled Syringes (30 mcg kits) to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. The award is not designated as a set-aside contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/11/25, 11:13 AM